Skip to main content

Betashares Global Healthcare ETF - Currency Hedged

DRUGBetasharesLast updated: Dec 25

What DRUG does

The Betashares Global Healthcare ETF - Currency Hedged (ticker: DRUG) allows investors to gain exposure to a diverse range of global healthcare companies. This ETF invests in a broad selection of healthcare firms, including those involved in pharmaceuticals, biotechnology, and medical equipment, providing a way to benefit from the growth and innovation in the healthcare sector worldwide. The currency hedging feature helps protect Australian investors from fluctuations in foreign exchange rates, ensuring that returns are more closely aligned with the actual performance of the underlying investments. With a management fee of 0.57%, this ETF offers a straightforward way to invest in the global healthcare industry while managing currency risk.

Management Fee

0.57%

Distribution Yield

0.31%

Fund Under Management

$172M

+10.16M

Monthly Liquidity

7.61%

Spread

0.20%

Last Price

...

Product Type

ETF

Monthly fund flows

Monthly Flow

$-3.53M

12-Month Flow

$-29.71M

Trading Activity

Transacted Value

$13M

Volume

1,540,371

Number of Trades

1,663

Monthly Liquidity

7.61%

Performance

1 Month

8.47%

1 Year

5.87%

3 Year

5.16%

5 Year

7.32%

Total Return

Share Price Chart

Related ETFs

Resources

Should you buy Betashares Global Healthcare ETF - Currency Hedged right now?

While DRUG looks interesting right now, our experts have just put together a full report on the ultimate ASX investment portfolio - designed for growth and passive income.

Join the Rask weekly investment newsletter to get the names, right now